1997 Fiscal Year Final Research Report Summary
Study on the development of therapy for insulin-dependent diabetes melitus addressing the regulation of pancreatic beta-cells death.
Project/Area Number |
07557354
|
Research Category |
Grant-in-Aid for Scientific Research (A)
|
Allocation Type | Single-year Grants |
Section | 展開研究 |
Research Field |
内分泌・代謝学
|
Research Institution | Nagasaki University |
Principal Investigator |
KONDO Takahito Nagasaki University, School of Medicine, Professor, 医学部, 教授 (00158908)
|
Co-Investigator(Kenkyū-buntansha) |
TOMONAGA Masao Nagasaki University, School of Medicine, Professor, 医学部, 教授 (40100854)
YAMASHITA Shunichi Nagasaki University, School of Medicine, Professor, 医学部, 教授 (30200679)
|
Project Period (FY) |
1995 – 1997
|
Keywords | gamma-glutamylcysteine / glutathione / ribozyme / IDDM / beta-Cell / redox / NF-_kB / TNF-alpha |
Research Abstract |
Development of gene therapy for IDDM addressing regration of pancreatic beta-cell death. We used mouse pancreatic beta-cell lines, Min-6 and beta-TC as materials. We estimated antioxidant activities, insulin secretion, expression of preproinsulin gene, and analyzed the preproinsulin gene promoter. beta-cell damage was estimated as DNA damage induced by the treatment of these cells with TNF-alpha and IL- 1beta. To regulate the antioxidant activity and redox, we cloned the gene of gamma-glutamylcysteine synthetase (gamma-GCS), the rate-limiting enzyme for the glutathione (GSH) synthesis, and analyzed the 5'-flanking region of gamma-GCS gene. To suppress the expression of gamma-GCS,beta-cells were transfected with antisense codon of gamma-GCS constructed with ribozyme. Results 1. Levels of GSH and activities of GSH related enzymes decreased by 90% in Min-6 and beta-TC cells compared to other mouse tissues cells, suggesting beta-cells are feasible to oxidative stress and possess less redox activity. 2. The insulin secretion was down-regulated by GSH. 3. The expression of preproinsulin was not regulated by GSH. 4. GSH protected beta-cell damage by cytokines. 5. Transfection of anti-gamma-GCS-ribozyme caused of increase in insulin-secretion. 6. These data suggest low concentration of GSH in beta-cells is essential for the insulin secretion while sensitive to cellular damage by oxidants. Collectively, new gene therapy targeting the suppression of GSH synthesis thought to be effective to IDDM.
|